Pages that link to "Q57161777"
The following pages link to Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA (Q57161777):
Displaying 13 items.
- Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation (Q61443474) (← links)
- Mechanisms of hepatocellular carcinoma progression (Q64274830) (← links)
- Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers (Q90115736) (← links)
- Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects (Q90136092) (← links)
- Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors (Q90216774) (← links)
- Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma (Q90744981) (← links)
- ctcRbase: the gene expression database of circulating tumor cells and microemboli (Q91956291) (← links)
- Spatial and temporal expansion of intrahepatic metastasis by molecularly-defined clonality in multiple liver cancers (Q92035531) (← links)
- Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis (Q92250918) (← links)
- Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis (Q92759091) (← links)
- High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection (Q94571856) (← links)
- Advances in the early diagnosis of hepatocellular carcinoma (Q98946914) (← links)
- MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma (Q100750274) (← links)